<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04245241</url>
  </required_header>
  <id_info>
    <org_study_id>EIT-HFNC</org_study_id>
    <nct_id>NCT04245241</nct_id>
  </id_info>
  <brief_title>Effects of High-Flow Nasal Cannula Therapy Assessed by Electrical Impedance Tomography</brief_title>
  <official_title>Effects of High-Flow Nasal Cannula Therapy on Lung Recruitment and Lung Strain Change Assessed by Electrical Impedance Tomography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking Union Medical College Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aimed to determine the effects of HFNC therapy on lung recruitment and lung strain
      change assessed by electrical impedance tomography (EIT)
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2018</start_date>
  <completion_date type="Actual">November 1, 2019</completion_date>
  <primary_completion_date type="Actual">July 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>lung regional ventilation distribution</measure>
    <time_frame>minute 80</time_frame>
    <description>lung regional ventilation distribution measured by EIT</description>
  </primary_outcome>
  <enrollment type="Actual">24</enrollment>
  <condition>High-flow Nasal Cannula</condition>
  <condition>Electrical Impedance Tomography</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High-flow nasal cannula (HFNC)</intervention_name>
    <description>24 patients who receiving HFNC within 24 hours after extubation were prospectively enrolled in this study. EIT was used to monitor regional lung ventilation distributions at baseline (conventional oxygen therapy) and three flow rate levels of HFNC therapy (20, 40 and 60 L/min).</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        adult critically ill patients, who received a HENC therapy within 24 h after the
        extubation, were enrolled.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        -  Inclusion Criteria:

          -  Patient who received a HENC therapy within 24 h after the extubation

        Exclusion Criteria:

          -  Aged &lt;18 years

          -  Pregnancy

          -  Body mass index (BMI) over 50 kg/m2

          -  ribcage malformation .any contraindication of using EIT monitoring (automatic
             implantable cardioverter defibrillator, chest skin injury, etc.).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences,</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 20, 2020</study_first_submitted>
  <study_first_submitted_qc>January 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 28, 2020</study_first_posted>
  <last_update_submitted>January 25, 2020</last_update_submitted>
  <last_update_submitted_qc>January 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

